Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)
Clinical trial NCT03734991 · COMPLETED
Trial details
- NCT number
- NCT03734991
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-04
- Primary completion
- 2019-08-21
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.